No, TB. I'm not a client of Evans and Partners.
Are you saying that David Nayagam has done a report on PYC?
- Forums
- ASX - By Stock
- PYC
- Ann: Successful Toxicology Studies Pave Way for Human Trials
PYC
pyc therapeutics limited
Add to My Watchlist
5.22%
!
$1.31

Ann: Successful Toxicology Studies Pave Way for Human Trials, page-74
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.31 |
Change
0.065(5.22%) |
Mkt cap ! $771.3M |
Open | High | Low | Value | Volume |
$1.27 | $1.33 | $1.21 | $608.7K | 478.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 548 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 2723 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 836 | 1.310 |
1 | 434 | 1.305 |
1 | 434 | 1.295 |
1 | 40000 | 1.220 |
3 | 3833 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 3771 | 4 |
1.325 | 2264 | 1 |
1.330 | 6855 | 1 |
1.335 | 2247 | 1 |
1.340 | 18000 | 1 |
Last trade - 14.56pm 08/08/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |